Nav: Home

Designer worm spit supercharges healing

May 25, 2017

Every day 12 Australian diabetics have a limb amputated because of a non-healing wound. Globally, it's one every 30 seconds.

A molecule produced by a Thai liver parasite could be the solution to those non-healing wounds - and scientists from the Australian Institute of Tropical Health and Medicine (AITHM) are now able to produce a version of the molecule on a large enough scale to make it available for laboratory tests and eventually clinical trials.

The molecule is granulin, one of a family of protein growth factors involved with cell proliferation.

"It's produced by a parasitic liver fluke, Opisthorchis viverrini, which originally came to our attention because it causes a liver cancer that kills 26,000 people each year in Thailand," parasitologist Dr Michael Smout said.

As part of their work on a potential vaccine to protect people from the parasite, Dr Smout and colleagues established that the granulin it produces has a hidden talent - it supercharges healing.

"We realised the molecule, discovered in worm spit, could offer a solution for non-healing wounds, which are a problem for diabetics, smokers and the elderly," he said.

With fellow researchers from the AITHM at James Cook University in Cairns, Dr Smout has been investigating ways to produce granulin in sufficient quantities for larger-scale testing.

The team first tried recombinant DNA techniques, effectively inserting granulin into bacteria, with the aim of producing plentiful supplies of a reliable copy of the molecule.

"Unfortunately, granulin didn't perform well when we introduced it to E. coli bacteria, so we couldn't use recombinant techniques to produce a testable supply," said Professor Norelle Daly, whose research involves exploring the potential of peptides as drug candidates for therapeutic applications.

"We had to go back to the drawing board and find a way to synthesize part of the molecule - to build our own version of designer worm spit," she said.

The researchers worked to establish which parts of the molecule were critical to wound healing, and to find a way to reproduce the active parts of granulin molecules (peptides).

Nuclear Magnetic Resonance (NMR) spectroscopy revealed the molecule's complex shape: a string of amino acids bent into a twisted 3D shape that includes hairpin bends.

"In biology the shape and fold of a molecule can be critical to its function," Dr Smout said. "Getting the fold right is important - it can be like the difference between throwing a well folded paper plane, or tossing a crumpled ball of paper."

After testing different segments and structures, the team concluded that those hairpin bends were the key.

"They're held in the twisted 3-D shape by disulfide bonds, and surprisingly we've found that by introducing an extra, non-native, bond we can produce peptides that hold the right shape to promote healing," Professor Daly said.

"You could say we've found an extra fold that helps our peptide paper plane fly straight and target wounds."

The lab-produced granulin peptides have shown great promise in tests, driving cell proliferation in human cells grown in lab plates, and demonstrating potent wound healing in mice.

Now that they can mass-produce perfectly folded, wound-healing peptides, the researchers are looking for potential partners as they progress towards further testing and eventually clinical trials.

"We have plenty of work to do before clinical trials, but we're confident we have a very strong contender for what could one day be a cream that a diabetic could apply at home, avoiding a lengthy hospital stay and possible amputation," said Professor Alex Loukas, whose work includes the investigation of hookworm proteins to treat autoimmune and allergic diseases.

"A take-home cream would be a great step forward for those with chronic wounds, and it would also save our health system a great deal of money.

"One in every seven diabetics in Australia will have a non-healing wound at some point, and many suffer amputations as a result. It's estimated the long hospital stays involved in treating chronic wounds cost our healthcare system AU$3.7 billion per year."

The research is published in the latest edition of the Journal of Medicinal Chemistry.
-end-


James Cook University

Related Clinical Trials Articles:

Giving children a voice in clinical trials
Children as young as 8 years old with incurable cancer can reliably characterize the impact an experimental therapy has on their symptoms and quality of life -- even at the earliest stages of drug development -- making self-reported patient outcomes a potential new clinical trial endpoint.
Better health for women involved in clinical trials
Women who participate in obstetric and gynecology clinical trials experience improved health outcomes compared to those who are not involved in trials, according to research by Queen Mary University of London.
Final artificial pancreas clinical trials now open
Clinical trials are now enrolling to provide the final tests for a University of Virginia-developed artificial pancreas to automatically monitor and regulate blood-sugar levels in people with type 1 diabetes.
Why the bar needs to be raised for human clinical trials
Standards for authorizing first-time trials of drugs in humans are lax, and should be strengthened in several ways, McGill University researchers argue in a paper published today in Nature.
New drug formulary will help expedite use of agents in clinical trials
The National Cancer Institute (NCI) today launched a new drug formulary (the 'NCI Formulary') that will enable investigators at NCI-designated Cancer Centers to have quicker access to approved and investigational agents for use in preclinical studies and cancer clinical trials.
More Clinical Trials News and Clinical Trials Current Events

Best Science Podcasts 2019

We have hand picked the best science podcasts for 2019. Sit back and enjoy new science podcasts updated daily from your favorite science news services and scientists.
Now Playing: TED Radio Hour

Anthropomorphic
Do animals grieve? Do they have language or consciousness? For a long time, scientists resisted the urge to look for human qualities in animals. This hour, TED speakers explore how that is changing. Guests include biological anthropologist Barbara King, dolphin researcher Denise Herzing, primatologist Frans de Waal, and ecologist Carl Safina.
Now Playing: Science for the People

#534 Bacteria are Coming for Your OJ
What makes breakfast, breakfast? Well, according to every movie and TV show we've ever seen, a big glass of orange juice is basically required. But our morning grapefruit might be in danger. Why? Citrus greening, a bacteria carried by a bug, has infected 90% of the citrus groves in Florida. It's coming for your OJ. We'll talk with University of Maryland plant virologist Anne Simon about ways to stop the citrus killer, and with science writer and journalist Maryn McKenna about why throwing antibiotics at the problem is probably not the solution. Related links: A Review of the Citrus Greening...